anmelden
OMX Nordic 40
2.615,70
PKT
-0,53
PKT
-0,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.08.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.08.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.08.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.08.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.08.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 20.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.08.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 16.08.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 16.08.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.08.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.08.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.08.18 | AstraZeneca Reduce | HSBC | |
| 14.08.18 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 13.08.18 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 13.08.18 | Novo Nordisk Underweight | Barclays Capital | |
| 10.08.18 | AstraZeneca overweight | Barclays Capital | |
| 09.08.18 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.08.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 09.08.18 | Novo Nordisk Neutral | Credit Suisse Group | |
| 09.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.08.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 08.08.18 | Novo Nordisk Hold | Commerzbank AG | |
| 08.08.18 | Novo Nordisk buy | UBS AG | |
| 08.08.18 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.08.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 08.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.08.18 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 07.08.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.08.18 | Nokia buy | Deutsche Bank AG | |
| 03.08.18 | Volvo (B) Sell | UBS AG | |
| 03.08.18 | Novo Nordisk Hold | Commerzbank AG | |
| 02.08.18 | Volvo (B) Sell | UBS AG | |
| 02.08.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.08.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 31.07.18 | Nokia Neutral | Credit Suisse Group | |
| 31.07.18 | Nokia buy | Société Générale Group S.A. (SG) | |
| 30.07.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.07.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.07.18 | Nokia buy | UBS AG | |
| 30.07.18 | AstraZeneca Neutral | UBS AG |